Researchers discovered a mechanism that reprograms tumor cells in patients with advanced prostate cancer, reducing their response to anti-androgen therapy.
An experimental urine test that detects genetic changes associated with prostate cancer identified 92 percent of men with elevated PSA levels who had more aggressive disease.
By tracing cancers back to their cells of origin, Columbia researchers are learning why some cancers become aggressive.
Two genes together drive the most lethal forms of prostate cancer; could lead to diagnostic test and new treatments.
Utilizing the latest techniques in molecular biology and genetics, the married team of Cory Abate-Shen and Michael Shen are tackling metastatic prostate cancer.
A new genetic test may help determine which men with early prostate cancer can avoid surgery or other invasive treatment.